1. MiR-9-5p Inhibits Glioblastoma Cells Proliferation Through Directly Targeting FOXP2 (Forkhead Box P2)
    Hongbo Zhang et al, 2019, Frontiers in Oncology CrossRef
  2. The role of microRNA-9 in ovarian and cervical cancers: An updated overview
    Riccardo Di Fiore et al, 2024, European Journal of Surgical Oncology CrossRef
  3. MicroRNA‐9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4
    Hersi Mohamed Hersi et al, 2018, Molecular Oncology CrossRef
  4. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: Potential pharmacological targets for cancer therapy
    Subhankar Bose et al, 2022, Seminars in Cancer Biology CrossRef
  5. NUMB suppression by miR-9-5P enhances CD44+ prostate cancer stem cell growth and metastasis
    Xuan Wang et al, 2021, Scientific Reports CrossRef
  6. A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches
    Reyhaneh Aghayousefi et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
  7. miR-9-5p Exerts a Dual Role in Cervical Cancer and Targets Transcription Factor TWIST1
    Iris Babion et al, 2019, Cells CrossRef
  8. An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension
    Weifang Zhang et al, 2021, BioMed Research International CrossRef
  9. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer
    E. A. Braga et al, 2018, Bulletin of Experimental Biology and Medicine CrossRef
  10. MicroRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4
    Jun Yi et al, 2019, International Journal of Biological Macromolecules CrossRef
  11. Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells
    Yi-Chung Chien et al, 2020, Cancers CrossRef
  12. Effect of bevacizumab combined with chemotherapy on SDF-1 and CXCR4 in epithelial ovarian cancer and its prognosis
    Chunyan Ma, 2022, World Journal of Surgical Oncology CrossRef
  13. RETRACTED: Differential expression of miR-130a-3p modulate ovarian epithelial carcinoma (OEC) cell development and could be a biomarker for OEC
    May Mohammed Alrashed et al, 2021, Journal of Reproductive Immunology CrossRef
  14. Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm
    Mushtaq Ahmad Nengroo et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  15. miR-9 Does Not Regulate Lamin A Expression in Metastatic Cells from Lung Adenocarcinoma
    Julien Guinde et al, 2020, International Journal of Molecular Sciences CrossRef
  16. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis
    Li Zuo et al, 2021, Journal of Ovarian Research CrossRef
  17. The long non-coding RNA TUG1-miR-9a-5p axis contributes to ischemic injuries by promoting cardiomyocyte apoptosis via targeting KLF5
    Di Yang et al, 2019, Cell Death & Disease CrossRef
  18. Circulating and Tissue microRNAs as Biomarkers for Ovarian Cancer Prognosis
    Seyed Mostafa Parizadeh et al, 2019, Current Drug Targets CrossRef
  19. Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
    Guangmeng Xu et al, 2021, Discover Oncology CrossRef
  20. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
    Jing Zhang et al, 2021, BioMed Research International CrossRef
  21. miR-9a regulates levels of both rhomboid mRNA and protein in the early Drosophila melanogaster embryo
    Lorenzo Gallicchio et al, 2022, G3 Genes|Genomes|Genetics CrossRef
  22. Diverse roles of miRNAs in breast cancer and gynecologic cancers
    Naveen Soni et al, 2024, MicroRNA in Human Infectious Diseases CrossRef